We also identified the protein neuropilin 2 (NRP2) as a downstream target of miR-196a-3p, and showed that blocking NRP2 expression potently antagonized TGF-β promigratory effects in invasive breast cancer cells. This evidence concerns the gene TGFB1 and breast carcinoma.